Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Free Cash Flow (2016 - 2025)

Macrogenics (MGNX) has disclosed Free Cash Flow for 14 consecutive years, with $44.6 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 215.92% to $44.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$81.1 million through Dec 2025, down 18.43% year-over-year, with the annual reading at -$81.1 million for FY2025, 18.43% down from the prior year.
  • Free Cash Flow for Q4 2025 was $44.6 million at Macrogenics, up from -$30.6 million in the prior quarter.
  • The five-year high for Free Cash Flow was $62.7 million in Q3 2024, with the low at -$59.1 million in Q1 2022.
  • Average Free Cash Flow over 5 years is -$23.2 million, with a median of -$32.9 million recorded in 2023.
  • Peak annual rise in Free Cash Flow hit 277.82% in 2024, while the deepest fall reached 2079.03% in 2024.
  • Over 5 years, Free Cash Flow stood at -$50.0 million in 2021, then skyrocketed by 151.99% to $26.0 million in 2022, then plummeted by 214.02% to -$29.6 million in 2023, then decreased by 29.94% to -$38.5 million in 2024, then skyrocketed by 215.92% to $44.6 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at $44.6 million, -$30.6 million, and -$47.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.